| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/20/2011 | CN102018877A Traditional Chinese medicine for promoting psychological and physiological wounds to heal |
| 04/20/2011 | CN102018863A Medicine paste with functions of diminishing inflammation, relieving pain, activating blood circulation and dissipating blood stasis and manufacturing method thereof |
| 04/20/2011 | CN102018851A Nine-ingredient papaya numbness-relieving capsules and preparation method thereof |
| 04/20/2011 | CN102018835A Method for separating effective components in traditional Chinese medicine curculigo orchioides by membrane separation method |
| 04/20/2011 | CN102018833A Orally-taken and externally-used traditional Chinese medicine composition for treating cervical vertebra hyperplasia |
| 04/20/2011 | CN102018821A Chinese medicament for treating hypertrophic rachitis |
| 04/20/2011 | CN102018806A Gardenin channel-relaxing powder and preparation method thereof |
| 04/20/2011 | CN102018798A Poria cocos and angelica sinensis capsule for setting a bone and preparation method thereof |
| 04/20/2011 | CN102018792A Traditional Chinese medicine for treating ankylosing spondylitis |
| 04/20/2011 | CN102018784A Pseudo-ginseng and safflower capsule for activating blood circulation and preparation method thereof |
| 04/20/2011 | CN102018769A Radix gentianae macrophyllae and snake wine for dispelling wind and dredging channels and preparation method thereof |
| 04/20/2011 | CN102018736A Natural indigo decoction piece and preparation method thereof |
| 04/20/2011 | CN102018733A Application of myrica nana cheval to preparing traditional Chinese medicines for treating osteoporosis |
| 04/20/2011 | CN102018715A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 04/20/2011 | CN102018705A Pharmaceutical composition containing febuxostat crystals and preparation method thereof |
| 04/20/2011 | CN102018698A Compounds and methods for treating estrogen receptor-related diseases |
| 04/20/2011 | CN102018674A Diclofenac sodium hydrogel microballoon with pH sensitivity, preparation method and application thereof |
| 04/20/2011 | CN102018671A Estradiol transdermal spray and preparation method thereof |
| 04/20/2011 | CN102018659A Intestine positioning preparation of glycyrrhetic acid, glycyrrhetinic acid and salts of glycyrrhetic acid and glycyrrhetinic acid, and preparation method and application thereof |
| 04/20/2011 | CN102018593A Healing stone pillow for treating cervical spondylosis |
| 04/20/2011 | CN102018406A Drug pillow for treating cervical spondylosis |
| 04/20/2011 | CN102018405A Medicine pillow for treating scapulohumeral periarthritis |
| 04/20/2011 | CN101721568B Pharmaceutical composition for treating rheumatic arthralgia and preparation method thereof |
| 04/20/2011 | CN101708264B Chinese medicinal composition for treating lumbar and cervical disc herniation and spinal stenosis |
| 04/20/2011 | CN101708254B Chinese medicinal decoction for treating chronic lumbar vertebrae anti-pain lateral curvatura |
| 04/20/2011 | CN101690769B External medicament for treating hyperosteogeny and preparation method thereof |
| 04/20/2011 | CN101690768B Vein and artery relieving pills for impediment of sinew |
| 04/20/2011 | CN101612272B Chinese medicine for treating rheumatism and rheumatoid diseases |
| 04/20/2011 | CN101607022B Chinese medicament bone-knitting pellet preparation |
| 04/20/2011 | CN101590036B Application of epoxydiene taken as inhibitor of proinflammatory mediators |
| 04/20/2011 | CN101564422B Chinese medicament for treating diabetic gout |
| 04/20/2011 | CN101543562B Chinese medicament for treating prolapse of lumbar intervertebral disc |
| 04/20/2011 | CN101518588B Traditional Chinese medicine for treating diabetic arthrodynia |
| 04/20/2011 | CN101455704B Traditional Chinese medicine composition capable of preventing and treating osteoporosis and preparation method thereof |
| 04/20/2011 | CN101402688B Fusion protein, encoding gene and uses thereof |
| 04/20/2011 | CN101401934B T cell component vaccine for preventing and/or treating immune correlated diseases |
| 04/20/2011 | CN101385810B Traditional Chinese medicine composition containing chinemys reevesii for treating dermatomyositis and preparation thereof |
| 04/20/2011 | CN101385805B Traditional Chinese medicine composition containing cicada-shell for treating dermatomyositis and preparation thereof |
| 04/20/2011 | CN101380453B Oral powder and external plaster for treating hyperosteogeny and atrophic arthritis and production method thereof |
| 04/20/2011 | CN101309678B Medicament for use in connection with cartilage impairment |
| 04/20/2011 | CN101301460B Rheumatism paste for resolving stasis |
| 04/20/2011 | CN101259200B Orally-administered and externally-applied specific medicine for treating bone injury disease, protrusion of lumbar intervertebral discs and wrick |
| 04/20/2011 | CN101164557B Medical composition for preventing and/or treating bone matrix's loss |
| 04/20/2011 | CN101141956B Use of CRTH2 antagonist compounds in therapy,its preparation method and pharmaceutical uses |
| 04/20/2011 | CN101129541B Medicament for treating bone joint disease |
| 04/20/2011 | CN101095941B Novel use of leuprorelin acetate in the preventing and treating of osteoporosis |
| 04/20/2011 | CN101053614B Flesh and blood healing external applied anti-infectious powder and its medicine preparation |
| 04/20/2011 | CN100998637B Traditional Chinese medicine for treating bone tuberculosis and arthritis |
| 04/19/2011 | US7928255 Intermediates for the preparation of lipoxin A4 analogs |
| 04/19/2011 | US7928227 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/19/2011 | US7928130 Isoxazoline compounds having MIF antagonist activity |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928078 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 04/19/2011 | US7927852 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2474674C Solid preparation containing single crystal form |
| 04/19/2011 | CA2458452C Gnrh agonist combination drugs |
| 04/19/2011 | CA2394430C A calcium absorption enhancing agent and a method for producing it |
| 04/19/2011 | CA2385659C Novel antiarrhythmic peptides |
| 04/19/2011 | CA2362496C Polypeptide variants with increased heparin-binding ability |
| 04/14/2011 | WO2011044452A2 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences |
| 04/14/2011 | WO2011044443A2 Matricryptic ecm peptides for tissue reconstruction |
| 04/14/2011 | WO2011043453A1 Activator for peroxisome proliferator activated receptor |
| 04/14/2011 | WO2011043371A1 Oxazole compound |
| 04/14/2011 | WO2011043136A1 Immunosuppressing agent comprising mesenchymal stem cell derived from adipose tissue, and use thereof |
| 04/14/2011 | WO2011042890A2 Use of phenolic compounds for protein deglycolysation |
| 04/14/2011 | WO2011042474A1 Novel estrogen receptor ligands |
| 04/14/2011 | WO2011042473A2 Novel estrogen receptor ligands |
| 04/14/2011 | WO2011042469A1 Use of a compound based on eremophilanolides |
| 04/14/2011 | WO2011041894A1 Siglec 15 antibodies in treating bone loss-related disease |
| 04/14/2011 | WO2011041865A1 Pharmaceutical composition containin an apitoxin fraction and use thereof |
| 04/14/2011 | WO2010123243A3 Composition containing a testis extract for treating or preventing diseases |
| 04/14/2011 | US20110087152 Fluidic tissue augmentation compositions and methods |
| 04/14/2011 | US20110086921 Novel Polymorphic Forms of (4--2-Methylphenyl)Carbonyl]Amino}-3-Methylphenyl)Acetic Acid |
| 04/14/2011 | US20110086919 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 04/14/2011 | US20110086899 Pharmaceutical compositions for oral administration |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086891 Solid Forms of 2-(2,4-Difluorophenyl)-6-(1-(2,6-Difluorophenyl)Ureido)Nicotinamide) |
| 04/14/2011 | US20110086864 N-hydroxyamide derivatives and use thereof |
| 04/14/2011 | US20110086857 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/14/2011 | US20110086856 Compositions useful as inhibitors of protein kinases |
| 04/14/2011 | US20110086846 Azaindazole Compounds As CCR1 Receptor Antagonists |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086096 Modified release 1- [ (3-hydroxy-adamant-1-ylamino)-acetyl] -pyrrolidine-2 (s) -carbonitrile formulation |
| 04/14/2011 | US20110086080 Ex-vivo production of human demineralized bone matrix |
| 04/14/2011 | US20110086057 OX40R Binding Agents |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086021 Sclerostin and the inhibition of WNT signaling and bone formation |
| 04/14/2011 | US20110086017 Medical Food composition and methods for management of inflammatory processes in mammals |
| 04/14/2011 | US20110086011 Prevention or Treatment of Immune-Relevant Disease by Modification of Microfloral Populations |
| 04/14/2011 | US20110086008 Composition and method for the repair and regeneration of cartilage and other tissues |
| 04/14/2011 | US20110085979 Conjugate of a polymer, an anti-angiogenesis agent and a targeting moiety, and uses thereof in the treatment of bone related angiogenesis conditions |
| 04/14/2011 | US20110085968 Articles comprising nano-materials for geometry-guided stem cell differentiation and enhanced bone growth |
| 04/14/2011 | US20110083991 Hyaluronic acid derivative and drug containing the same |